Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clark C Chen

Showing results (181-190 of 296) with videos related to

Pageof 30
Sort By:
Journal of Neurology, Neurosurgery, and Psychiatry|May 24, 2011
A review of lumbar spinal instrumentation: evidence and controversyMaya A Babu, Jean-Valery C Coumans, Bob S Carter, et al.
World Neurosurgery|January 9, 2018
Interaction Between the Contributions of Tumor Location, Tumor Grade, and Patient Age to the Survival Benefit Associated with Gross Total ResectionKate T Carroll, Alex K Bryant, Brian Hirshman, et al.
Journal of Neuro-Oncology|June 20, 2020
Glioblastomas located in proximity to the subventricular zone (SVZ) exhibited enrichment of gene expression profiles associated with the cancer stem cell stateTyler C Steed, Jeffrey M Treiber, Birra Taha, et al.
Journal of Neuro-Oncology|September 1, 2011
Cyberknife hypofractionated stereotactic radiosurgery (HSRS) of resection cavity after excision of large cerebral metastasis: efficacy and safety of an 800 cGy × 3 daily fractions regimenChe-Chuan Wang, Scott R Floyd, Chin-Hong Chang, et al.
Neuro-Oncology Advances|January 28, 2021
An integrated disease-specific graded prognostic assessment scale for melanoma: contributions of KPS, CITV, number of metastases, and BRAF mutation statusManmeet Ahluwalia, Mir A Ali, Rushikesh S Joshi, et al.
Journal of Neuro-Oncology|May 16, 2013
Immediate post-operative brachytherapy prior to irradiation and temozolomide for newly diagnosed glioblastomaJ Dawn Waters, Brent Rose, David D Gonda, et al.
Journal of Neurosurgery|May 16, 2025
Trends in glioblastoma treatment, survival, and disparities in access to care in the United States from 2004 to 2019: a National Cancer Database analysisJohn Pham, Jonathan Sisti, David J Cote, et al.
Neuro-Oncology|May 10, 2012
miR-181d: a predictive glioblastoma biomarker that downregulates MGMT expressionWei Zhang, Jing Zhang, Katherine Hoadley, et al.
Journal of Neuro-Oncology|February 5, 2025
Treatment practices and survival outcomes for IDH-wildtype glioblastoma patients according to MGMT promoter methylation status: insights from the U.S. National Cancer DatabaseJohn Pham, David J Cote, Keiko Kang, et al.
Journal of Neurosurgery|August 5, 2017
Impact of neurosurgeon specialization on patient outcomes for intracranial and spinal surgery: a retrospective analysis of the Nationwide Inpatient Sample 1998-2009Brandon A McCutcheon, Brian R Hirshman, Brandon C Gabel, et al.
Pageof 30

Showing results (181-190 of 296) with videos related to

Sort By:
Pageof 30
Journal of Neurology, Neurosurgery, and Psychiatry|May 24, 2011
A review of lumbar spinal instrumentation: evidence and controversyMaya A Babu, Jean-Valery C Coumans, Bob S Carter, et al.
World Neurosurgery|January 9, 2018
Interaction Between the Contributions of Tumor Location, Tumor Grade, and Patient Age to the Survival Benefit Associated with Gross Total ResectionKate T Carroll, Alex K Bryant, Brian Hirshman, et al.
Journal of Neuro-Oncology|June 20, 2020
Glioblastomas located in proximity to the subventricular zone (SVZ) exhibited enrichment of gene expression profiles associated with the cancer stem cell stateTyler C Steed, Jeffrey M Treiber, Birra Taha, et al.
Journal of Neuro-Oncology|September 1, 2011
Cyberknife hypofractionated stereotactic radiosurgery (HSRS) of resection cavity after excision of large cerebral metastasis: efficacy and safety of an 800 cGy × 3 daily fractions regimenChe-Chuan Wang, Scott R Floyd, Chin-Hong Chang, et al.
Neuro-Oncology Advances|January 28, 2021
An integrated disease-specific graded prognostic assessment scale for melanoma: contributions of KPS, CITV, number of metastases, and BRAF mutation statusManmeet Ahluwalia, Mir A Ali, Rushikesh S Joshi, et al.
Journal of Neuro-Oncology|May 16, 2013
Immediate post-operative brachytherapy prior to irradiation and temozolomide for newly diagnosed glioblastomaJ Dawn Waters, Brent Rose, David D Gonda, et al.
Journal of Neurosurgery|May 16, 2025
Trends in glioblastoma treatment, survival, and disparities in access to care in the United States from 2004 to 2019: a National Cancer Database analysisJohn Pham, Jonathan Sisti, David J Cote, et al.
Neuro-Oncology|May 10, 2012
miR-181d: a predictive glioblastoma biomarker that downregulates MGMT expressionWei Zhang, Jing Zhang, Katherine Hoadley, et al.
Journal of Neuro-Oncology|February 5, 2025
Treatment practices and survival outcomes for IDH-wildtype glioblastoma patients according to MGMT promoter methylation status: insights from the U.S. National Cancer DatabaseJohn Pham, David J Cote, Keiko Kang, et al.
Journal of Neurosurgery|August 5, 2017
Impact of neurosurgeon specialization on patient outcomes for intracranial and spinal surgery: a retrospective analysis of the Nationwide Inpatient Sample 1998-2009Brandon A McCutcheon, Brian R Hirshman, Brandon C Gabel, et al.
Pageof 30